Tenet completes $1B surgery center acquisition
This is the second billion-dollar deal with SurgCenter Development in as many years as Tenet continues building out its surgery center footprint, a key component of its long-term strategy.
This is the second billion-dollar deal with SurgCenter Development in as many years as Tenet continues building out its surgery center footprint, a key component of its long-term strategy.
Ashley McEvoy is confident that 2022 will not be as bad as the first or second year of the COVID-19 pandemic, even as the omicron variant drives cases up, but adds that “we’re not out of the woods yet.”
Paxlovid is the first oral treatment for COVID-19, a potentially valuable new tool as the fast-spreading omicron variant fuels a sharp surge in cases across the U.S.
Effective Jan. 1, the average list price for Aduhelm will drop about 50% to just over $28,000 a year. It’s a move the company hopes will appease insurers and lower out-of-pocket costs for patients.
Soon, the payer will begin searching for Michael Neidorff’s successor, kicking off an executive search for the first time since he was installed in 1996.
The high court blocked a challenge to New Mexico’s statewide vaccine mandate for healthcare workers Tuesday. The CMS vaccine mandate remains in place, though injunctions in some states still stand.
The use of “low-quality data” is reasonable at the start of a crisis but FDA should consider raising the standard of evidence after multiple products come to market, according to the authors of the study.
As the omicron variant spreads rapidly, the White House is mobilizing federal agencies to assist hospitals and states in the latest wave of infection.
The system said it can hire two of its own nurses or surgical technologists for the price of one contracted through an outside agency.
The rebates, tied to lower medical loss ratios, were triggered as utilization rates dropped at the start of the COVID-19 pandemic.